Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.280
-0.060 (-4.48%)
At close: Oct 29, 2025, 4:00 PM EDT
1.300
+0.020 (1.55%)
After-hours: Oct 29, 2025, 7:53 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.99 million as of October 29, 2025. Its market cap has increased by 124.78% in one year.
Market Cap
2.99M
Enterprise Value
-2.18M
1-Year Change
124.78%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $2.99M, a decrease of -96.69%. That is a compound annual growth rate of -49.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 3.13M | -18.63% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
| Nov 17, 2020 | 90.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.59B |
| Johnson & Johnson | 453.66B |
| AbbVie | 401.93B |
| UnitedHealth Group | 331.85B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 222.57B |